The Board of Optiscan Imaging Limited announced the appointment of Mr. Sean Gardiner as a non-executive director of the Company. Pursuant to clause 7.1 of the Subscription Agreement between Optiscan and Orchid Capital Investments Pte. Ltd. dated 21 September 2020, Orchid Capital Investments Pte.

Ltd. nominates Mr. Sean Gardiner as its new "Subscriber Nominee" (as defined in the Subscription Agreement) to Optiscan's Board of Directors. Sean is a Managing Director and Head of Private Investments at the Clermont Group. Prior to joining Clermont, Sean worked at Morgan Stanley, where he spent 20 years in equity research across three locations and in seven different roles.

In 2000, he joined the London office covering European Technology and Conglomerate stocks before, in 2005, moving to lead the EEMEA Telecom Services team. In early 2008, Sean transferred to Dubai to setup and manage the MENA Equity Research team. Sean relocated to Singapore in 2010 to oversee and manage the broader Asian research product as well as roll out ASEAN Real Estate coverage.

In 2016, he was promoted to Head of ASEAN Research and ASEAN Equity Strategist. Prior to Morgan Stanley, Sean served his Chartered Accountancy articles in South Africa and he has a B.Com (PGDA) from the University of Cape Town.